Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

1.

Update of dalbavancin spectrum and potency in the USA: report from the SENTRY Antimicrobial Surveillance Program (2011).

Jones RN, Sader HS, Flamm RK.

Diagn Microbiol Infect Dis. 2013 Mar;75(3):304-7. doi: 10.1016/j.diagmicrobio.2012.11.024. Epub 2013 Jan 26.

PMID:
23357293
[PubMed - indexed for MEDLINE]
2.

Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).

Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.

Int J Antimicrob Agents. 2007 Aug;30(2):143-9. Epub 2007 May 24.

PMID:
17531446
[PubMed - indexed for MEDLINE]
3.

[Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].

Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R; SENTRY Surveillance Program, Spain (2002-2006).

Enferm Infecc Microbiol Clin. 2008 Oct;26(8):489-94. Spanish.

PMID:
19094861
[PubMed - indexed for MEDLINE]
4.

Multicenter evaluation of the in vitro activity of dalbavancin tested against staphylococci and streptococci in 5 European countries: results from the DECIDE Surveillance Program (2007).

Biedenbach DJ, Jones RN.

Diagn Microbiol Infect Dis. 2009 Jun;64(2):177-84. doi: 10.1016/j.diagmicrobio.2008.12.019. Epub 2009 Feb 26.

PMID:
19249179
[PubMed - indexed for MEDLINE]
5.

Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).

Jones RN, Stilwell MG, Sader HS, Fritsche TR, Goldstein BP.

Diagn Microbiol Infect Dis. 2006 Feb;54(2):149-53. Epub 2006 Jan 19.

PMID:
16426793
[PubMed - indexed for MEDLINE]
6.

Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.

Streit JM, Sader HS, Fritsche TR, Jones RN.

Diagn Microbiol Infect Dis. 2005 Dec;53(4):307-10.

PMID:
15922534
[PubMed - indexed for MEDLINE]
7.
8.

Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).

Sader HS, Moet GJ, Farrell DJ, Jones RN.

Diagn Microbiol Infect Dis. 2011 Jul;70(3):412-6. doi: 10.1016/j.diagmicrobio.2011.02.008. Epub 2011 May 4.

PMID:
21546202
[PubMed - indexed for MEDLINE]
9.

Antimicrobial susceptibility of gram-positive bacteria isolated in Brazilian hospitals participating in the SENTRY Program (2005-2008).

Gales AC, Sader HS, Ribeiro J, Zoccoli C, Barth A, Pignatari AC.

Braz J Infect Dis. 2009 Apr;13(2):90-8.

PMID:
20140350
[PubMed - indexed for MEDLINE]
Free Article
10.

Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011.

Sader HS, Flamm RK, Jones RN.

Antimicrob Agents Chemother. 2013 Jul;57(7):3178-81. doi: 10.1128/AAC.00484-13. Epub 2013 Apr 29.

PMID:
23629712
[PubMed - indexed for MEDLINE]
Free PMC Article
11.
12.

Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.

Biedenbach DJ, Ross JE, Fritsche TR, Sader HS, Jones RN.

J Clin Microbiol. 2007 Mar;45(3):998-1004. Epub 2007 Jan 10.

PMID:
17215346
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.

Felmingham D, Brown DF, Soussy CJ.

Diagn Microbiol Infect Dis. 1998 Aug;31(4):563-71.

PMID:
9764397
[PubMed - indexed for MEDLINE]
14.

Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).

Sader HS, Jones RN.

Diagn Microbiol Infect Dis. 2009 Oct;65(2):158-62. doi: 10.1016/j.diagmicrobio.2009.06.016.

PMID:
19748426
[PubMed - indexed for MEDLINE]
15.

Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011).

Sader HS, Flamm RK, Jones RN.

Diagn Microbiol Infect Dis. 2013 Apr;75(4):417-22. doi: 10.1016/j.diagmicrobio.2013.01.001.

PMID:
23514757
[PubMed - indexed for MEDLINE]
16.

Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000).

Gordon KA, Beach ML, Biedenbach DJ, Jones RN, Rhomberg PR, Mutnick AH.

Diagn Microbiol Infect Dis. 2002 Jun;43(2):157-62.

PMID:
12088624
[PubMed - indexed for MEDLINE]
17.

Antimicrobial properties of MX-2401, an expanded-spectrum lipopeptide active in the presence of lung surfactant.

Dugourd D, Yang H, Elliott M, Siu R, Clement JJ, Straus SK, Hancock RE, Rubinchik E.

Antimicrob Agents Chemother. 2011 Aug;55(8):3720-8. doi: 10.1128/AAC.00322-11. Epub 2011 May 16.

PMID:
21576435
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.

Jones RN, Ross JE, Bell JM, Utsuki U, Fumiaki I, Kobayashi I, Turnidge JD.

Diagn Microbiol Infect Dis. 2009 Dec;65(4):404-13. doi: 10.1016/j.diagmicrobio.2009.10.001.

PMID:
19913683
[PubMed - indexed for MEDLINE]
19.

Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance Program.

Sader HS, Flamm RK, Farrell DJ, Jones RN.

Clin Infect Dis. 2012 Sep;55 Suppl 3:S181-6. doi: 10.1093/cid/cis560.

PMID:
22903950
[PubMed - indexed for MEDLINE]
Free Article
20.

Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).

Sader HS, Streit JM, Fritsche TR, Jones RN.

Clin Microbiol Infect. 2006 Sep;12(9):844-52.

PMID:
16882289
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk